T1	Participants 129 176	patients with cirrhosis and variceal hemorrhage
T2	Participants 331 375	cirrhotic patients with medium/large varices
T3	Participants 439 508	Three hundred fourteen patients with grades 2 or 3 esophageal varices
T4	Participants 554 633	One hundred seventy-three patients had no previous history of variceal bleeding
T5	Participants 640 793	245 patients (100% of patients with prior variceal hemorrhage, 61% of patients without prior hemorrhage) were receiving some form of prophylactic therapy
